From: Effects of surgeon variability on oncologic and functional outcomes in a population-based setting
All patients N = 1,280 | |||
---|---|---|---|
Age at surgery, median years (IQR) | 64 | (60,67) | |
PSA at diagnosis, median (IQR) ng/mL (Missing n=3) | 6.3 | (4.5,9.8) | |
Follow-up for biochemical recurrence, median years (IQR) | 5.28 | (3.59-6.83) | |
n | (%) | ||
Pathological Gleason score (Missing n=2) | ≤ 6 | 593 | (46.5) |
7 | 624 | (48.9) | |
≥ 8 | 59 | (4.6) | |
No tumor found | 2 | - | |
Nerve-sparing surgery (Missing n=3) | No | 625 | (48.9) |
Unilateral | 196 | (15.3) | |
Bilateral | 456 | (35.7) | |
Surgical margins (Missing n=5) | Positive | 333 | (26.1) |
Negative | 942 | (73.9) | |
Seminal vesicle invasion (Missing n=16) | Yes | 109 | (8.6) |
No | 1155 | (91.4) | |
Pathological stage (Missing n=7) | pT0 | 2 | (0.2) |
pT2 | 906 | (71.2) | |
pT3 | 365 | (28.7) | |
Preoperative erectile function (Missing n=241) | Potent | 679 | (65.4) |
Impotent | 360 | (34.7) | |
Postoperative erectile function at 18 months (Missing n=633) | Potent | 122 | (18.9) |
Impotent | 525 | (81.1) | |
Preoperative urinary function (Missing n=202) | Continent | 1053 | (97.7) |
Incontinent | 25 | (2.3) | |
Postoperative urinary function at 18 months (Missing n=301) | Continent | 836 | (85.4) |
Incontinent | 143 | (14.6) |